Retrospective and Prospective Study of POmalidomide Plus LoW Dose Dexa Efficacy in RRMM Patients Under Real-Life Conditions

Clinical trial NCT03353545 · COMPLETED

Trial details

NCT number: NCT03353545
Sponsor: Genesis Pharma S.A.
Status: COMPLETED
Study type: OBSERVATIONAL

Relapse/Refractory Multiple Myeloma

Start date: 2017-11-16
Primary completion: 2020-02-21
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.